Skip to main content

Table 4 Comparison of the incidence of adverse events

From: Comparison of the efficacy and safety of remimazolam and propofol for fiberoptic bronchoscopy in older patients: a prospective, randomized controlled study

 

Group R (n = 30)

Group P (n = 30)

P value

Injection pain, n (%)

0(0%)

7(23.3%)

0.01*

Hiccup

1(3.3%)

0(0%)

0.31

Vertigo

3(10%)

2(6.7%)

0.64

PONV

2(6.7%)

1(3.3%)

0.55

  1. Abbreviations: PONV, postoperative nausea and vomiting
  2. *P < 0.05 vs. Group P
Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us